INNOVATE Corp. (VATE)
| Market Cap | 76.39M +7.3% |
| Revenue (ttm) | 1.52B +52.4% |
| Net Income | -24.00M |
| EPS | -1.81 |
| Shares Out | 13.64M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 49,669 |
| Open | 5.53 |
| Previous Close | 5.61 |
| Day's Range | 5.45 - 5.69 |
| 52-Week Range | 3.75 - 21.30 |
| Beta | 2.44 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 11, 2026 |
About VATE
INNOVATE Corp., through its subsidiaries, operates in infrastructure, life sciences, and spectrum areas in the United States. The company operates through the Infrastructure, Life Sciences, and Spectrum segments. The Infrastructure segment provides industrial construction, structural steel, and facility maintenance services, such as fabrication and erection of structural steel and heavy steel plate services, and large-diameter water pipes and water storage tanks; fabrication of trusses and girders; 3-D building information modeling and detailin... [Read more]
Financial Performance
In 2025, INNOVATE's revenue was $1.25 billion, an increase of 12.55% compared to the previous year's $1.11 billion. Losses were -$64.00 million, 78.8% more than in 2024.
Financial StatementsNews
INNOVATE Completes Sale of DBM Global to IES Holdings
NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE: VATE) (“INNOVATE”) announced today that it has completed the previously announced sale of DBM Global, Inc. (“DBMG”) to IES Holdings, ...
INNOVATE Announces Closing of the Sale of a Controlling Interest in its Broadcasting Segment to CONX
NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.
INNOVATE Registration statement: Registration filing
INNOVATE filed a registration statement on August 19, 2026, providing details about a securities offering with the SEC.
MediBeacon® Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology
NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE: VATE) (“INNOVATE”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in the advancement ...
Innovate trading halted, volatility trading pause
10:35 EDT Innovate trading halted, volatility trading pause
INNOVATE Corp. files $100M mixed securities shelf
08:36 EDT INNOVATE Corp. (VATE) files $100M mixed securities shelf
IES Holdings to acquire DBM Global from INNOVATE Corp. for $650M
IES Holdings (IESC) announced that it has entered into a definitive agreement to acquire DBM Global from INNOVATE (VATE). The consideration for DBM Global, including minority interests, is approximate...
IES Holdings to Acquire DBM Global
HOUSTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- IES Holdings, Inc. (“IES”) (NASDAQ: IESC) today announced that it has entered into a definitive agreement to acquire DBM Global Inc. (“DBM Global”), a vertic...
INNOVATE Agrees to $650 Million Sale of DBM Global to IES Holdings
NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE: VATE) (“INNOVATE”) announced today that it has entered into a Transaction Agreement (the “Agreement”) pursuant to which IES Holdings,...
INNOVATE Registration statement: Registration filing
INNOVATE filed a registration statement on August 10, 2026, providing details about a securities offering with the SEC.
INNOVATE Earnings Call Transcript: Q2 2026
Q2 2026 revenue surged 74.2% year-over-year to $421.6 million, driven by record Infrastructure results and margin expansion. Net income reached $10.4 million, reversing a prior loss, while strategic refinancing and a pending Broadcasting sale strengthened the balance sheet.
INNOVATE Slides: Q2 2026
INNOVATE has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
INNOVATE Earnings release: Q2 2026
INNOVATE released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
INNOVATE Quarterly report: Q2 2026
INNOVATE has published its Q2 2026 quarterly earnings report on August 6, 2026.
INNOVATE Corp. to Report Second Quarter 2026 Results on August 6th
NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the second quarter 2026 on Thursda...
INNOVATE's Portfolio Company DBM Global to Pay Cash Dividend
NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE:VATE) (“INNOVATE” or the “Company”) announced today that DBM Global Inc. (“DBMG”), a family of companies providing fully integrated st...
INNOVATE Transcript: AGM 2026
Directors and executive officers were introduced, and all four shareholder proposals—including director elections, executive compensation, equity plan amendment, and auditor ratification—were approved. No questions were submitted during the Q&A session.
INNOVATE Announces Successful Closing of Broadcasting Refinancing and Agrees to Partial Sale of Broadcasting
NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that HC2 Broadcasting Holdings Inc. (“Broadcasting”) closed on a refinancing trans...
INNOVATE Earnings Call Transcript: Q1 2026
Q1 2026 saw 33% revenue growth to $364.8M and improved adjusted EBITDA, driven by infrastructure gains, while Life Sciences and Spectrum faced revenue declines. Net loss narrowed, cash increased, and backlog remains strong, supporting a positive outlook.
INNOVATE Slides: Q1 2026
INNOVATE has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 14, 2026.
INNOVATE Earnings release: Q1 2026
INNOVATE released its Q1 2026 earnings on May 14, 2026, summarizing the period's financial results.
INNOVATE Quarterly report: Q1 2026
INNOVATE has published its Q1 2026 quarterly earnings report on May 14, 2026.
INNOVATE Corp. Announces First Quarter 2026 Results
- Infrastructure: Strong first quarter results with revenue of $357.9 million - Life Sciences: MediBeacon receives the CE mark for the Transdermal GFR Monitor and Reusable Sensor - Spectrum: More tha...
INNOVATE Proxy statement: Proxy filing
INNOVATE filed a proxy statement on April 28, 2026, providing details for shareholder voting and corporate governance matters.